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ABSTRACT

MUTAGENICITY OF ROOT CANAL SEALER RSA ROEKOSEAL AUTOMIX
IN THE AMES TEST
By Joseph Anthony Wateska, DMD
The mutagenic activity of the root canal sealing cement, RSA Roekoseal Automix,
was tested in the bacterial gene mutation assay (Ames test). Root canal sealing cement
AHPlus was also tested and used as a comparison. Both materials were mixed according
to the manufacturer’s instruction and tested immediately after mixing and after a setting
time of 24 h at 37ºC in a 100% humidified chamber. The set material was powdered and
both the freshly mixed and powdered material were eluted in dimethyl sulfoxide (DMSO)
for 24h at 37ºC. Aliquots of serially diluted eluates were then used in the standard plate
incorporation assay. The Salmonella typhimurium tester strains TA98 and TA100 were
used to detect the induction of frameshift mutations and base pair substitutions both in the
presence and absence of a metabolically active microsomal fraction from rat liver (S9
fraction). No mutagenic or toxic effects were found with DMSO eluates of freshly mixed
or 24h set RSA Roekoseal Automix. However, DMSO eluates of the freshly mixed and
24 hr set AHPlus was mutagenic in tester strain TA98 at higher concentrations in a dose
related manner. Eluates of the freshly mixed AHPlus were mutagenic in tester strain TA
100 in a dose related manner in the absence of metabolically active S9 fraction. Eluates
of the AHPlus material set for 24h were mutagenic in the tester strain TA100 in a dose
related manner in the presence and absence of S9. The AHPlus set material was more
toxic than the freshly mixed material at higher concentrations. Therefore, we conclude
that RSA Roekoseal Automix is nonmutagenic and nontoxic in S. typhimurium TA98 and
TA100. Also, both freshly mixed and 24h set RSA Roekoseal Automix is less mutagenic
than AHPlus in TA98 and TA100 with and without the presence of S9 mix.
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CHAPTER I
INTRODUCTION

BACKGROUND
Elimination of microorganisms from the root canal system by instrumentation and
irrigation is essential for the overall success of root canal therapy.

The antimicrobial

activity of root canal sealers helps to play an important rule in the elimination of any
remaining bacteria (18).

Substances present in some of the sealers such as

paraformaldehyde, eugenol, and thymol help to destroy these bacteria (1). On the other
hand, these endodontic filling materials may have a toxic and mutagenic affect on the
periapical soft tissues, thereby canceling the potential benefits of the antimicrobial
properties of the materials (2). Various studies have revealed that elutable substances or
degradation or corrosion products from root canal fillings may gain access to surrounding
tissues through various connections, e.g., dentinal tubules, accessory and lateral canals,
and apical foramina (3).
It has been demonstrated that zinc oxide eugenol-containing materials were
moderately to severely toxic in implant studies. Severe inflammation was observed when
the cements were injected into subcutaneous connective tissue of rabbits (4). Whereas,
formaldehyde-containing materials have been shown to induce severe periapical
inflammation even after a few months’ observation period (5).

In contrast to these

findings, a glass ionomer root canal sealer (Ketac-Endo) was tissue compatible, with only
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a mild inflammatory reaction after exposure for five days (6). Calcium hydroxide-based
filling sealers have shown mild to moderate tissue-irritating activities and have been
demonstrated to have no mutagenic potential (4,15). No formaldehyde or other marked
cytotoxic and mutagenic ingredients are known to be released from the calcium
hydroxide based sealers, e.g., Sealapex and Apexit (9).

AH26, a resin-based sealer,

caused severe tissue inflammation after only a few days in various biocompatibility
studies, however, only mild tissue reactions were reported from long- term investigations
(7). AH26 has been shown to release formaldehyde after mixing, with a maximum
release after 2 days (8).
The mutagenic effects of root canal sealers have been addressed in the past. A resinbased material, AH26, was mutagenic in the Salmonella/microsome assay (Ames Test)
and when tested in mammalian cells in vitro (10,11,15). It was determined that bisphenol
A diglycidylether was the most likely mutagenic component of a resin-based material,
although formaldehyde could have added to this effect (12). The mutagenicity of AH
Plus was also tested in a bacterial gene mutation assay, the Ames test. This study
concluded that AHPlus was mutagenic under certain experimental conditions and that
more than likely the epoxy resin present in this sealer was the mutagenic component (13).
Whereas, another similar test concluded that AHPlus was mutagenic dependant upon the
setting period after mixing (22).
Many endodontic materials have been tested over the years for there mutagenic
effects, but no studies have tested the mutagenicity of RSA Roekoseal Automix (Roeko
USA, Monrovia, CA). RSA Roekoseal Automix is a polydimethylsiloxane based root
canal sealer that has been recently introduced for root canal therapy.
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In the present study, the mutagenicity of the polydimethylsiloxane based RSA
Roekoseal Automix and resin based AHPlus (Dentsply USA, York, PA) root canal sealer
will be tested immediately after mixing and after a setting time of 24h. Two different
Salmonella typhimurium tester strains, TA98 and TA100, will be used to investigate
material-induced gene mutations via the Ames test, reverse-mutation assay.

STATEMENT OF PROBLEM
Root canal sealers are routinely used in conventional root canal therapy. Some
endodontic materials have been shown to have a mutagenic potential to the surrounding
periradicular tissues. Will a new root canal sealer, RSA Roekoseal Automix have a
mutagenic potential?

SIGNIFICANCE OF THE PROBLEM
Adverse material effects may play an important role in the failure of endodontic
treatment, even if no major fault can be identified in treatment. Therefore, only those
root canal sealers that are biocompatible and display no mutagenic potential should be
used in conventional root canal therapy. This demands that each endodontic material
should be evaluated for its mutagenic potential before clinical application. For example,
sealers with inferior biocompatibility, such as formaldehyde-releasing materials, should
no longer be applied during treatment. RSA Roekoseal Automix, a new
polydimethylsiloxane endodontic sealer, claims to be a superior endodontic sealer when
compared to others. However, the mutagenic potential of RSA Roekoseal Automix has
not been determined. If RSA Roekoseal Automix can be shown to be non-mutagenic as
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defined by the Ames test, perhaps it can be accepted for use in conventional root canal
therapy.

HYPOTHESIS
RSA Roekoseal Automix will be non mutagenic as evaluated by the Ames test,
reverse-mutation assay.
RSA Roekoseal Automix will be less mutagenic than AHPlus as evaluated by the
Ames test, reverse-mutation assay.

OPERATIONAL DEFINITIONS
The following terms are defined for clarification:
1. Mutagenicity - The property of being able to induce genetic
mutation.
2. Root canal sealer – A radiopaque dental cement used, usually in
combination with a solid or semi-solid core material, to fill voids and to
seal root canals during obturation.
3. Anaerobe – a microorganism that lives and grows in complete, or
almost complete, absence of molecular oxygen.
4. Gram-negative – losing the stain or decolorized by alcohol in
Gram’s method of staining, a primary characteristic of certain
microorganisms.
5. Gram-positive – retaining the stain or resisting decolorization by
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alcohol in Gram’s method of staining, a primary characteristic of certain
microorganisms.
6. Facultative anaerobe - microorganisms that are able to grow
under either anaerobic or aerobic conditions.
7. Obligate anaerobe – microorganisms that are able to grow only
in the complete absence of molecular oxygen; some are killed by
oxygen.
8. Frameshift Mutation – mutations which result in an addition (+) or
deletion (-) of one or more nucleotides in a sequence of mRNA causing
a reading frameshift of the trinucleotide sequences.
9. Base-pair substitution – The replacement of a single base in DNA by
by another base, causing a mutation.
10. Auxotrophic bacteria – Bacteria requiring a growth factor that is not
required by the parental or prototype strain; said of microbial mutants.
11. Eluate – The substance separated out by, or the product of elution.

LIMITATIONS
1. This study was conducted using an in vitro model
2. It was not the intent to simulate exact clinical populations of bacteria but use
certain quantified bacteria only as a measuring tool to determine the
mutagenicity of RSA Roekoseal Automix, and AHPlus.
3. The tester strains used in the Ames test are of non-endodontic origin.
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DELIMITATIONS
1. The endodontic sealers used were RSA Roekoseal Automix (Roeko USA,
Monrovia, CA), and AHPlus (Dentsply USA, York, PA).

ASSUMPTIONS
Elimination of the microorganisms from the root canal system is essential to the
overall success of conventional root canal therapy.
Endodontic sealers are useful in limiting micro leakage of the root canal system.
The Ames test, reverse mutation gene assay, is an accepted method for testing the
potential of material-induced gene mutations.
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CHAPTER II
REVIEW OF LITERATURE

Elimination of microorganisms from the root canal system is crucial in the overall
success of conventional root canal therapy. Repair of the periapical area has been
reported where sufficient removal of large numbers of organisms together with inflamed
necrotic tissue and inflammatory products has been accomplished by mechanical and
chemo mechanical cleansing and debridement (35)(36). Bacteria and their bi-products
that stimulate organic reactions are the main cause of pathological changes in the root
canal and associated periapical areas. Low oxygen tension, nutrient supply, and loss of
natural defense after pulpal necrosis, benefit microorganism interaction (37) (38).
Anaerobic and aerobic flora has been isolated from endodontic infections. In 1997,
Chaudhry, Kalra, Talwar and Thakur evaluated microbiological and clinical data from 56
patients with endodontic infections. Forty-nine positive cultures were obtained from the
56 consecutive necrotic root canal systems, which were sampled. Aerobic bacteria were
isolated from 72%, anaerobic bacteria from 6% and mixed aerobic and anaerobic bacteria
from 22% of the samples. The most common aerobic isolate was Klebsiella pneumonia
while Bacteroides was the most common anaerobic species. Their results illustrated the
poly-microbial nature of endodontic infections and the role of anaerobic bacteria (16). In
1999, Baumgartner, Watkins, Bae and Xia were able to isolate black-pigmented bacteria
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(i.e. Prevotella and Porphyromonas species) from endodontic infections through
conventional laboratory methods. Black pigmented bacteria were shown to be associated
with purulent drainage either from the root canal or an associated sinus tract (17). E.
faecalis is among the few facultative organisms associated with persistent periapical
inflammation (39). This facultative organism has shown to be resistant to treatment (40).
B. fragilis can also be cultured from endodontic lesions and is representative of a gramnegative obligate rod (16).
In addition to having good sealing ability, and in order to minimize the incidence of
local and/or systemic side effects, the biocompatibility of all endodontic materials should
be analyzed by various in vitro and in vivo tests prior to clinical implication (23) (24).
The various in vitro tests include determination of antimicrobial effects, cytoxicity, and
mutagenicity of root canal sealers. In 1980, Grossman studied the antimicrobial effect of
eleven root canal cements. These cements were tested aerobically by the agar diffusion
method for their antimicrobial effect. Both those of the zinc oxide-type and of the
plastic-type exerted antimicrobial activity to a varying degree. Those cements containing
paraformaldehyde were more effective than those that did not contain this ingredient.
However, the effect of paraformaldehyde diminished with time (18).
In 1997, Fuss and Shalhav studied the antibacterial activity of calcium hydroxidecontaining endodontic sealers on Enterococcus faecalis in vitro. They showed that the
antimicrobial activity of each tested sealer changes differently with the time interval
between mixing and testing, suggesting different physicochemical properties and
potentially diverse clinical applications (19).
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Although many sealers may have antimicrobial activities, they have also been shown
to exert cytotoxic affects on the surrounding periapical tissues.

In 1990, Briseno and

Willershausen examined six different zinc oxide eugenol root canal sealers to determine
their cytotoxicity on human gingival fibroblasts. They found that these root canal sealers
were highly toxic to human gingival fibroblasts (20). In 1998, Osorio et al. used an in
vitro cell culture model of human gingival fibroblasts and L-929 cells to measure the
cytotoxicity of currently used root canal sealers Endomet, CRCS, and AH26. Statistical
analysis of the results showed that CRCS was the least cytotoxic sealer followed by
Endomet and AH26 (21).
Genotoxicity, mutagenicity and carcinogenicity are important factors affecting the
systemic compatability of an endodontic material. Genotoxicity means the presence of a
DNA-reactive component that may result in mutagenicity and carcinogenicity (25). Due
to the extremely serious and life threatening consequences, mutagenicity and
carcinogenicity are gaining increased public interest. Therefore, In vitro test systems for
genotoxicity have been used and can be differentiated into bacterial tests such as the
classic Ames test and the Umu test, and eukaryotic tests such as the DNA synthesis
inhibition test, the chromosomal aberration test, and the hypoxanthine-guanine
phosphoribosyltransferase test (HPGRT)(26) (27) (28). In 1985, Orstavik and Hongslo
studied the mutagenicity of four endodontic sealers by using the Ames test. Extracts of a
synthetic polymer material, based on epoxy-bis-phenol A, induced mutations in the
Salmonella typhimurium TA100 as did extracts of the epoxy-bis-phenol A resin alone.
Formaldehyde, an active ingredient from one of the ZnO-based materials, induced
mutations in both Salmonella typhimurium TA98 and TA100 (29).
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In 1999, Leyhausen et al. tested the cytotoxic and genotoxic effects of AHPlus by
means of the growth inhibition test with primary human periodontal ligament fibroblasts
and permanent 3T3 monolayers, the prokaryotic umu test, the eucaryotic DNA synthesis
inhibition test and the in vivo alkaline filter elution test. These tests results revealed that
AHPlus was neither genotoxic nor mutagenic (30). Shweikl also tested .the mutagenicity
of AH26 in an in vitro mammalian cell mutation assay. They concluded that eluates of
mixed AH26 were toxic and mutagenic, and both effects strongly depended on the setting
time. The mutagenic activity of the mixed AH26 was clearly reduced after a setting time
of one week (31). In 1996, Heil et al. demonstrated through three test methods, the
bacterial umu-test, the eukaryotic DNA synthesis inhibition test, and the in vivo alkaline
filter elution technique that AH26 elicited clear concentration- related genotoxic
responses (26).
In 1998, Schweikl et al showed that in addition to the root canal sealer AHPlus
being mutagenic after initial mixing to tester stain TA100 in a dose related manner, it was
also toxic in the presence of dimethyl sulfoxide (DMSO) and S9 (metabolically active
microsomal fraction of rat liver) in the Ames test (22). In 1997, Geurtsen et al. stated
that, “since various dental or endodontic materials are highly cytotoxic, it is a basic
requirement that genotoxicity tests easily quantify cytotoxicity simultaneously, in order
to avoid misinterpretation of the data” (27). In 1999, Ersev et al. determined in vitro the
cytotoxic and mutagenic effects of root canal filling cements of various chemical
compositions. L-929 mouse fibroblast cell cultures where used in the MTT test to
determine the cytotoxicity of various root canal filling materials and the Ames test was
used to determine their mutagenicity. He found that mixed silver free AH26 might
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contain small amounts of two mutagenic substances: bisphenol A diglycidyl ether and
formaldehyde (32).
The Ames test for endodontic materials is an accepted method of testing for the
mutagenicity of endodontic materials. The Ames test is included in the American Dental
Association’s Specification No. 41 (33), as well as the International Federation’s
Recommended Standard Practices for Biological Evaluation of Dental Materials (34).
The Ames test utilizes a gram-negative rod, Salmonella typhimurium tester strains,
TA98 and TA100. Although S. typhimurium is not found in endodontic infections, gramnegative rods are commonly cultured from endodontic lesions (16).
The salmonella test was first validated in a study of 300 chemicals, most of which
were known carcinogens (41). All validations show that the test fails to detect a few
classes of carcinogens such as polychlorinated pesticides. But the addition of cofactor S9
mix (rat liver enzymes) allows a detection of a wider variety of carcinogens requiring
metabolic activation. In 1981 Ames and McCann estimated the correlation between
mutagenicity and carcinogenicity to be approximately 83% (42).
TA 98 and TA100 are histidine-requiring Salmonella typhimurium tester strains that
are used in mutagenicity testing. The Ames test detects a histidine mutation in TA 100
in the hisG gene coding for the first enzyme of histidine biosynthesis (43).

This

mutation, determined by DNA sequencing analysis, substitutes proline for leucine in the
organism (44). TA100 detect mutagens that cause base pair substitutions (figure 1). The
histidine mutation in TA98 is in the hisD gene coding for histidinol dehydrogenase. TA
98 detects various frameshift mutations (figure 2). Spontaneous reversion of the tester
strains to histidine independence is measured routinely in mutagenicity experiments (i.e.
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Ames test) and is expressed as the number of spontaneous revertants per plate. The
revertant colonies are clearly visible in a uniform background lawn of auxotrophic
bacteria (44).
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DNA

CTA/GCA/TGA/GAG/GGG
GAT/CGA/ACT/CTC/CCC
leucine

mRNA

CUA/GCA/UGA/GAG/GGG
GGG for GAG

DNA

CTA/GCA/TGA/GGG/GGG
GAT/CGT/ACT/CCC/CCC
proline

mRNA

CUA/GCA/UGA/GGG/GGG

Figure 1. Base-pair substitution
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DNA

CTA/GCA/TGT/ATA/GGG
GAT/CGT/ACA/TAT/CCC

mRNA

CUA/GCA/UGU/AUA/GGG

G-C AND T-A added

DNA

mRNA

CTA/GGT/CAT/GTA/TAG/GG
GAT/CCA/GTA/CAT/ATC/CC

CUA/GGU/CAU/GUA/UAG/GG
Figure 2. Frameshift mutation
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CHAPTER III
MATERIALS AND METHODS

SAMPLE DESCRIPTION
This study involved two root canal sealers, RSA Roekoseal Automix (Langenau,
Germany) and AHPlus (York, PA). The composition of RSA Roekoseal Automix and
AHPlus, which was tested in this study, is shown in Table 1 and Table 2. The materials
were mixed according to the manufacturers instructions.

For testing the mutagenic

potencies in the Ames test, 1gram of each material, RSA Roekoseal Automix and
AHPlus, was eluted in 10ml dimethylsulfoxide (DMSO)(Sigma Lot# 87H3661) for 24
hours at 37°C immediately after mixing and after a setting period of 24 h at 37°C in
100% humidity. The set material was ground in a mortar before elution. Each sample
was vortexed for 2 minutes immediately after eluting in DMSO. After setting for 24 h,
each sample was serially diluted to final concentrations of 10, 5, 2.5, 1.25, .625 and
.312mg/0.1ml (mg/plate)(Figure 3). Each sample was stored in -20ºC until the Ames test
was performed. Positive controls, 2-Aminaoanthracene (2AA) and 1-Nitropyrene (1NP),
were used to confirm the reversion properties of each strain and efficacy of the
microsomal fraction from the rat liver (S9). DMSO was used as the negative control.
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Material
AHPlus (lot #
0009000417)
(Dentsply, USA,
York, PA)

Components

Ingredients

AHPlus Paste A
(lot0009000417 )

Epoxy resin
Calcium tungstate
Zirconium oxide
Aerosil
Iron oxide

AHPlus Paste B
(lot 0009000417)

Adamantane amine
N,N’-Dibenzoyl-5-oxanonane-diamine-1,9
TCD-diamine
Calcium tungstate
Zircomiun oxide
Silicone oil
Aerosil

Table 1. AHPlus and Ingredients

Material
RSA Roekoseal
Automix
(lot 2101745)
(Roeko, USA,
Monrovia, CA)

Components

Ingredients

RSA Roekoseal
Automix Paste A
base

Polydimethylsiloxane
Silicone oil
Paraffin-base oil
Zirconium dioxide (for radiopacity)

RSA Roekoseal
Automix Paste B
(catalyst)

Hexachloroplatinic acid

Table 2. RSA Roekoseal Automix and Ingredients
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Serial Dilution of RSA Roekoseal Automix
Remove 5ml solution

Remove 5ml solution

10ml

Tube #6
10mg/plate

Tube #5
5mg/plate

Add 5ml DMSO

Remove 5ml solution

Tube #3
1.25mg/plate

Add 5ml DMSO

Tube #4
2.5mg/plate

Add 5ml DMSO

Remove 5ml solution

Tube #2
0.625mg/plate

Add 5ml DMSO

Remove 5ml solution

Tube #1
0.312mg/plate

Add 5ml DMSO

Figure 3. Serial dilution of RSA Roekoseal Automix
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RESEARCH DESIGN
The Ames test, described by Bruce Ames (University of California, Berkely), was
employed to test the mutagenicity of a new root canal sealer RSA Roekoseal Automix
and a previously tested root canal sealer AHPlus. Each sealer was mixed according to
the manufacturer’s instructions and tested immediately after mixing and after a setting
time of 24h at 37ºC in 100% humidity.

METHODOLOGY
Cultures of Salmonella typhimurium tester strains, TA98 and TA100, were kindly
provided by Dr. Bruce N. Ames (University of California at Berkeley). The plate
incorporation test was carried out as follows:

PREPARATION OF TESTER STRAINS Salmonella typhimurium tester strain,
TA98 and TA100 are grown in oxoid nutrient broth No. 2 to a density of 1-2 x 109 cells
per ml. DMSO was added as a cryoprotective agent. The amount of culture required for
a mutagenicity assay depends on the size of the experiment and is based on 0.1ml of
culture per plate. The cultures were prepared by Dr. Mingzhen Cui from the National
Institute of Occupational Safety and Health, Morgantown, WV, and frozen permanent
copies were stored at -80ºC.

PREPARATION OF THE AGAR PLATES Dr. Mingzhen Cui prepared the agar
plates 24 hours prior to the experiment. The plates were prepared in accordance with the
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recommendations given by Dr. Bruce N. Ames.

Plates for the mutagenicity assay

contain 30ml of minimal glucose agar medium. The medium is 1.5% Bacto-Difco agar
and 2% glucose in Vogel-Bonner medium E. Sterile, disposable plastic petri plates
(100mm x 15mm) (Falcon No.1029) were used.

PREPARATION OF S-9 MIX

The S-9 mix was prepared on ice under a sterile

hood. The components of the S-9 mix and preparation are as follows:
S9 mixture: These ingredients were added together and kept on ice to prevent loss
of activity. The total volume prepared was 60ml S-9 mixture. An automated pipette was
used to prepare the required volumes of sample (Figure 4).
1.2ml S-9 salt (KCL¯, MgCl2)
0.3ml Glucose-6-Phosphate (Stored in -80ºC Forma Scientific Bio Freezer prior to
use)
2.4ml NADP (Stored in -80ºC Forma Scientific Bio Freezer prior to use)
30ml Phosphate Buffer, pH 7.4
20ml sterile H20
6.0 ml S-9 microsomal rat liver fraction (lot# 1107) (Stored in a freezer at –80ºC
Forma Scientific Bio Freezer prior to use)
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1.2ml S-9 salt
30ml Phosphate buffer
20ml sterile H2O
0.3ml Glucose-6-Phosphate
2.4ml NADP
6.0ml S-9 microsomal liver fraction

Mixing
container
Forma Scientific Biofreezer
Container of ice

-80ºC

Figure 4. Preparation of S-9 mixture
PREPARATION OF HISTIDINE / BIOTIN MIXTURE Histidine and biotin
were required by the tester strains for growth on the agar. 400ml Top agar containing
0.6% Difco agar and 0.5% NaCL was melted in a microwave oven for 2-3 minutes. 40ml
0.5mM Lhistidine/ biotin was added to the 400ml top agar and mixed by manually
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swirling the mixture. The mixture was then placed in a water bath at 45ºC (Precision
Scientific, Model 82, Chicago, Il.) and stored there until needed.

PLATE INCORPORATION TEST (AMES TEST) The plate incorporation test
consists of combining the test compound, the tester strain, and S-9 mix or physiological
saline (without S-9 mix) soft agar and pouring it onto a glucose minimal agar plate. All
glassware, reagents, media and petri plates used in the experiment were sterile. All
procedures were performed under a SterilGARD III Advance hood (The Baker Company,
Samford, Maine).
Each diluted test sample was tested in duplicate, in both tester strains TA98 and
TA100 and in the presence and absence of S-9 mix. All testing was performed in
accordance with the recommendations given by Bruce N. Ames, Biochemistry
department, University of California, Berkeley, CA 94720 (14).

Procedure: 0.1ml of each serially diluted test sample (AHPlus after mixing,
AHPlus after setting 24hours, RSA Roekoseal Automix after mixing and RSA Roekoseal
Automix after setting 24hours) was added to a 10ml test tube with a micropipette.
0.5ml S-9 mix, or 0.5ml physiological saline (without S-9), was added to the test sample.
The compound is tested in the presence and absence of S-9 mix. 0.1ml of the tester strain
(TA98 or TA100) was then added to the mixture.

After preparing the test sample

mixtures, they were vortexed (Vortex Genie 2) for 2 seconds, placed in a rotating tray
and incubated at 37ºC for 20 - 30 minutes in a Forma Scientific incubator.

The tubes

were slowly turned during the incubation. This is known as the pre-incubation phase first
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described by Yahagi et al in 1975 (45). This phase makes the tester strains more
sensitive to potential mutagens. After incubation, 2.5ml of the Histidine/Biotin top agar
mixture was added to each test sample using a Brinkmann dispensette. This mixture of
test sample, tester strain, S-9 mix or physiological saline and Histidine/Biotin made up
the soft (top) agar. Each test component was mixed by vortexing the soft agar for 2-3
seconds at low speed and then poured onto a minimal glucose agar plate. To achieve a
uniform distribution of the soft agar on the surface of each plate, the uncovered plate was
quickly tilted and rotated. Each plate was covered and placed under the sterile hood to
harden. The mixing, pouring, and distribution of each plate took less than 20 seconds and
the plates were left to harden for several minutes. Note: If the top agar begins to harden
in mid-operation a stippled surface will result which will make scoring of revertants
difficult. Belser et al. reported that the greatest source of variability in the test results is
non-uniformity of the soft (top) agar thickness (46).

Within 1 hour the plates were

inverted and placed in a dark, vented, 37ºC incubator for 48 hours. After 48 hours the
revertant colonies on the test plates and control plates were counted 3 separate times,
each time being from a different position, on an automated counter (Artek Counter,
Model 880, Dynatech Laboratories Inc.).

The presence of a background lawn of

auxotrophic bacteria on each plate was confirmed by analysis under an inverted
microscope (Leica DMIL) at 100x power. The condition of the background lawn was
labeled as being either good, fair, poor or toxic. A lawn that was thin compared to the
lawn on the negative control plate was evidence of bacterial toxicity. Colonies that
appeared without the presence of a background lawn were not revertants and were not
counted (figure 5).
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0.5ml S-9 mix (or physiologic saline)
0.1ml RSA Roekoseal Automix sample
0.1ml TA98 or TA100
Added to 10ml test tube
vortexed
for 2 sec

Sample mix is placed in a
rotating tray and incubated
at 37ºC for 20-30 minutes

Vortex
Genie 2

After preincubation
2.5ml Histidine/Biotin
top agar mix added

vortexed
for 2 sec

Sample mix is poured onto minimal glucose agar plate,
the plate was rotated and allowed to harden for 1 hour. The
sample was then allowed to incubate at 37ºC for 48hrs.

After 48 hours the number of revertant colonies were
counted using an automatic counter (Artek).

Figure 5. A Flowchart of the Ames test using the RSA Roekoseal Automix sample.
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SPONTANEOUS REVERSION Spontaneous reversion of the tester strains to
histidine independence was measured in the mutagenicity experiment and was expressed
as the number of spontaneous revertants per plate. The revertant colonies were clearly
visible in a uniform background lawn of auxotroph bacteria. Each tester strain reverted
spontaneously at a rate that was characteristic of the strain. The number of revertants that
arose in the 48-hour incubation period was dependant on the final number of auxotrophs
on the plate and that number was a function of the histidine concentration. The number
of auxotrophs was not counted but their number is assumed to be constant due to the
constant histidine concentration.

DATA COLLECTION / INSTRUMENTATION
Raw data sheets were used to collect the number of spontaneous revertants per
sampled minimal glucose agar plate as shown in Tables 1-7, Appendix A. An automatic
colony counter (Artek) was used to count the number of revertant colonies.

The

condition of the background lawn for each sample plate was noted on a raw data sheet
shown in Table 8, Appendix A. An inverted microscope (Leica, Germany), set at a
power of 100x was used to observe the condition of the background lawn as being either
good, fair, poor or toxic (Figure 6).
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Figure 6. Example of revertant colonies and inverted microscope.
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STATISTICAL TREATMENT
Dunnett’s Method was used to compare the sample means with the negative
control mean (Alpha = 0.05). An ANOVA was used to compare the tester strains TA98
and TA100.

EQUIPMENT AND MATERIALS
LARGE EQUIPMENT
1 SterilGARD III Advance laminar flow hood (The Baker Company, Samford, Maine)
1 Automatic colony counter (Artek Counter, Model 880)
1 Bio Freezer (-80ºC)
1 Water bath (Precision Scientific, Model 82, Chicago, Il.)
1 Forma Scientific stationary incubator
1 Inverted microscope (Leica DMIL, Leitz Wetzlar, Germany)

SMALL EQUIPMENT
Adjustable micropipettes
12 4.0ml glass vials (for test samples) with Teflon lined caps
232 Disposable glass culture tubes (13mm x 100mm)
Latex surgeon’s gloves
6 Plastic cryotubes for storage of S-9
1 Vortexer (Vortex Genie2)
6 Test tube racks
1 Electronic balance (American Scientific Products)
1Brinkmann dispensette
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1 package AHPlus sealer (Dentsply USA, York, PA)
1 package RSA Roekoseal Automix sealer (Roeko USA, Monrovia, CA)
1 Mixing pad
1 Spatula
1 Mortar and pestle
232 Plastic petri plates (Falcon #1029)
1 Humidified chamber (100% humidity)
Salmonella typhimurium tester strains TA98 and TA100 (Bruce Ames Laboratory,
Berkely, CA)
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CHAPTER IV
RESULTS AND DISCUSSION

RESULTS
MUTAGENICITY DMSO eluates of freshly mixed and 24h set RSA Roekoseal
Automix were nonmutagenic to tester strains TA98 and TA100 in the presence and
absence of S9. However, .312mg/plate of freshly mixed RSA Roekoseal Automix
without S9 mix displayed a significantly higher number of revertants as compared to the
negative control in tester strain TA100. DMSO eluates of freshly mixed and 24 h set
AHPlus with and without S9 mix were mutagenic to tester strain TA98 at a dose of
10mg/plate. DMSO eluates of freshly mixed and 24h set AHPlus with and without S9
were mutagenic to tester strain TA100 in a dose related manner. Appendix B displays
statistical analysis of each sample by means of Dunnett’s Method for comparing sample
means.
The effectiveness of the S9 liver fraction was verified by the positive control
2AA. 2AA is only mutagenic to tester strains TA98 and TA100 in the presence of S9.
This was demonstrated by a 10 – 30 fold increase in the number of revertants with S9 as
compared to without S9.
An analysis of variance comparing tester strains TA98 and TA100 demonstrated
that TA100 has a statistically significant greater amount of revertants colonies per plate
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than TA98. Thus verifying that the number of revertant colonies produced per plate was
a characteristic of the tester strain.
BACKGROUND LAWN TOXICITY

AHPlus after setting 24 hours at a

concentration of 10mg/plate was toxic to the TA100 tester strain (Figure 8). Freshly
mixed AHPlus showed no toxic effects at any concentration towards either TA98 or
TA100. Freshly mixed and 24 hour set RSA Roekoseal Automix showed no toxic effects
at any concentration towards either TA98 or TA100.

DISCUSSION
In the present study, the mutagenicity of the new polydimethylsiloxane based root
canal sealing cement, RSA Roekoseal automix, was tested using the Salmonella/
microsome gene mutation assay. Resin based root canal sealing cement, AHPlus, was
also tested in the same manner. The two tester strains, S. typhimurium TA98 and TA100,
were employed to detect the induction of frameshift and base-pair mutations. The mixed
samples of RSA Roekoseal Automix and AHPlus, which were set for 24 h, were first
chopped up (RSA Roekoseal Automix) and powdered (AHPlus) and then eluted in an
aqueous solvent. Therefore, the surface of the material is large in vitro, compared to the
amount of material that could extrude through the apical foramen to the periapical tissues
in vivo. These differences should be considered before these results can be extrapolated
into a clinical situation.
The mixed RSA Roekoseal Automix was nonmutagenic in this test under extreme
experimental conditions.

Only freshly mixed RSA Roekoseal at the lowest tested

concentration showed increased numbers of revertant colonies when compared to the
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negative control. This increase may have been attributed to an error in the amount of
histidine added to the top agar. Maron and Ames (1983) pointed out that the number of
revertants that arise in 48h incubation is dependant on the final number of auxotrophs on
the plate and that number is a function of the histidine concentration. Therefore, a slight
increase in histidine, due to human error, may have caused an increase in the number of
revertant colonies (14).
The findings that DMSO eluates of RSA Roekoseal Automix are nonmutagenic
provide evidence that the unpolymerized and polymerized ingredients are also
nonmutagenic in the test. Moreover, these findings also suggest that the unpolymerized
and polymerized ingredients of RSA Roekoseal Automix are nontoxic.
The mixed AHPlus was directly mutagenic in this test under extreme
experimental conditions, and the severity of this effect depended on the setting period
after mixing. Both freshly mixed and 24h set AHPlus induced a dose related increase in
the number of mutant numbers in strain TA100. The findings that AHPlus was more
mutagenic to tester strain TA100 indicate that the material induces more base pair
substitutions.

The direct mutagenicity of DMSO eluates of freshly mixed AHPlus

decreased in strain TA100 at higher concentrations in the presence of a metabolically
active microsomal fraction from rat liver (S9). Since DMSO eluates seemed to be more
toxic in the presence of S9, the mutagenic substance might have been converted to a toxic
component or a different substance was activated to a toxic metabolite.

Therefore, the

decrease in mutagenicity may have been a result of an increase in toxicity.
These findings provide evidence that one, or more, ingredients, which are
produced in the polymerized and unpolymerized material, elicit the mutagenic effect of
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DMSO eluates. It is most likely that the epoxy resin is the mutagenic ingredient in
AHPlus because of the very similar effects of this material compared to those elicited by
DMSO eluates of the mixed AH26 in a previous investigation. Evidence was provided
that the epoxy resin, bisphenol A diglycidalether, is the mutagenic compound of AH26
(29). Also, the findings of this experiment concerning the mutagenicity of AHPlus are
similar to those discovered by Schweikl et al. in 1998 (22).
Further in vitro and in vivo studies are needed to determine the clinical safety of
AHPlus root canal sealers. Also, further investigation is necessary in order to determine
whether the mutagenicity of AHPlus could result in bacterial resistance.
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CHAPTER V
SUMMARY AND CONCLUSION

SUMMARY
The mutagenic activity of the root canal sealing cement, RSA Roekoseal
Automix, was tested in the bacterial gene mutation assay (Ames test). Root canal sealing
cement AHPlus was also tested and used as a comparison. Both materials were mixed
according to the manufacturer’s instruction and tested immediately after mixing and after
a setting time of 24 h at 37ºC in a 100% humidified chamber. The set material was
powdered and both the freshly mixed and powdered material were eluted in dimethyl
sulfoxide (DMSO) for 24h at 37ºC. Aliquots of serially diluted eluates were then used in
the standard plate incorporation assay. The Salmonella typhimurium tester strains TA98
and TA100 were used to detect the induction of frameshift mutations and base pair
substitutions both in the presence and absence of a metabolically active microsomal
fraction from rat liver (S9 fraction). No mutagenic or toxic effects were found with
DMSO eluates of freshly mixed or 24h set RSA Roekoseal Automix. However, DMSO
eluates of the freshly mixed and 24 h set AHPlus was mutagenic in tester strain TA98 at
higher concentrations.

Eluates of the freshly mixed AHPlus were mutagenic in tester

strain TA 100 in a dose related manner in the absence of metabolically active S9 fraction.
Eluates of the AHPlus material set for 24h were mutagenic in the tester strain TA100 in a

32

dose related manner in the presence and absence of S9. The AHPlus set material was
more toxic than the freshly mixed material at higher concentrations.

CONCLUSION
In conclusion, RSA Roekoseal Automix is nonmutagenic and nontoxic in S.
typhimurium TA98 and TA100. Also, both freshly mixed and 24h set RSA Roekoseal
Automix is less mutagenic than AHPlus in TA98 and TA100 with and without the
presence of S9 mix. Therefore, RSA Roekoseal Automix is a safe root canal sealing
material and should be used freely in clinical situations. On the other hand, caution
should be advised before using AHPlus root canal sealer in a clinical situation. Further
investigation is needed before AHPlus can be safely applied.
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APPENDIX A
Raw Data Forms
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Ames Test --- Raw Data Sheets
Test Date: 3-27-2001
AHPlus after mixing
Concentration
Tester
Mg/plate

TA98

+ S9
Revertants per plate
1
2
3
Mean

- S9
Revertants per plate
1
2
3
mean

+ S9
Revertants per plate
1
2
3
mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

AHPlus after mixing
Concentration
tester
Mg/plate

TA100

- S9
Revertants per plate
1
2
3
Mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

Table 3. Mutagenicity of dimethyl sulfoxide (DMSO) eluates of freshly mixed AHPlus.
One gram of freshly mixed AHPlus was eluted in 10 ml DMSO for 24h and aliquots of
the original eluate were tested with Samonella typhimurium strains TA98 and TA100 in
the presence and in the absence of microsomal fraction from rat liver (S9).
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Test Date: 3-27-2001
AHPlus after setting 24h
Concentration
tester
Mg/plate

TA98

+ S9
Revertants per plate
1
2
3
mean

- S9
Revertants per plate
1
2
3
Mean

+ S9
Revertants per plate
1
2
3
Mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

AHPlus after setting 24h
Concentration
tester
Mg/plate

TA100

- S9
Revertants per plate
1
2
3
mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

Table 4. Mutagenicity of DMSO eluates of mixed AHPlus after setting for 24h. One
gram of mixed AHPlus that was set for 24h was then eluted in 10ml DMSO for 24h.
Aliquots of the original eluate were tested with Salmonella typhimurium strains TA98
and TA100 in the presence and in the absence of microsomal fraction from liver rat (S9).
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Test Date: 3-27-2001
RSA Roekoseal after mixing
Concentration
tester
Mg/plate

TA98

+ S9
Revertants per plate
1
2
3
Mean

- S9
Revertants per plate
1
2
3
Mean

+ S9
Revertants per plate
1
2
3
Mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

RSA Roekoseal after mixing
Concentration
tester
Mg/plate

TA100

- S9
Revertants per plate
1
2
3
Mean

10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

Table 5. Mutagenicity of dimethyl sulfoxide (DMSO) eluates of freshly mixed RSA
Roekoseal Automix. One gram of freshly mixed RSA Roekoseal Automix was eluted in
10 ml DMSO for 24h and aliquots of the original eluate were tested with Samonella
typhimurium strains TA98 and TA100 in the presence and in the absence of microsomal
fraction from rat liver (S9).

41

Test Date: 3-27-2001
RSA Roekoseal after setting 24h
Concentration
tester
- S9
Mg/plate
Revertants per plate
1
2
3
Mean
10mg/.1ml
TA98

+ S9
Revertants per plate
1
2
3
Mean

10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml
1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

RSA Roekoseal after setting 24h
Concentration
- S9
tester
Mg/plate
Revertants per plate
1
2
3
Mean
TA100
10mg/.1ml
10mg/.1ml
5mg/.1ml
5mg/.1ml
2.5mg/.1ml
2.5mg/.1ml

+ S9
Revertants per plate
1
2
3
Mean

1.25mg/.1ml
1.25mg/.1ml
.625mg/.1ml
.625mg/.1ml
.312mg/.1ml
.312mg/.1ml

Table 6. Mutagenicity of DMSO eluates of mixed RSA Roekoseal Automix after setting
for 24h. One gram of mixed RSA Roekoseal Automix that was set for 24h was then
eluted in 10ml DMSO for 24h. Aliquots of the original eluate were tested with
Salmonella typhimurium strains TA98 and TA100 in the presence and in the absence of
microsomal fraction from liver rat (S9).
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Test Date: 3-27-2001
Negative control: DMSO
Concentration
tester
ul/plate

- S9
Revertants per plate
1
2
3
Mean

+ S9
Revertants per plate
1
2
3
Mean

TA98

10ul/.1ml
10ul/.1ml
TA100
10ul/.1ml
10ul/.1ml
Table 7. Negative control DMSO. Spontaneous revertants per plate
Positive control: 2AA
Concentration
tester
ul/plate

- S9
Revertants per plate
1
2
3
Mean

+ S9
Revertants per plate
1
2
3
Mean

TA 98

2.5ul/plate
2.5ul/plate
TA100
2.5ul/plate
2.5ul/plate
5.0ul/plate
5.0ul/plate
Table 8. Positive control 2AA. Mutagenicity of a known mutagenic chemical.
Positive control: 1-NP
Concentration
tester
ul/plate

- S9
Revertants per plate
1
2
3
Mean

TA 98

+ S9
Revertants per plate
1
2
3
Mean

1.0ul/plate
1.0ul/plate
TA100
2.5ul/plate
2.5ul/plate
5.0ul/plate
5.0ul/plate
Table 9. Positive control 1-NP. Mutagenicity of a known mutagenic chemical.
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Ames test background lawn condition
Test date: 3-30-2001

Sample

Concentration

TA98
-S9
1

AHPlus wet

10mg/plate
5.0mg/plate
2.5mg/plate
1.25mg/plate
0.625mg/plate
0.312mg/plate

AHPlus set

10mg/plate
5.0mg/plate
2.5mg/plate
1.25mg/plate
0.625mg/plate
0.312mg/plate

RSA Roekoseal
wet

RSA Roekoseal
dry

10mg/plate
5.0mg/plate
2.5mg/plate
1.25mg/plate
0.625mg/plate
0.312mg/plate
10mg/plate
5.0mg/plate
2.5mg/plate
1.25mg/plate
0.625mg/plate
0.312mg/plate
44

2

+S9
1
2

TA100
-S9
+S9
1
2 1
2

TA98
Sample

-S9

Concentration

1
DMSO

10ul/plate

2AA

2.5ul/plate
5.0ul/plate

1-NP

1.0ul/plate
2.5ul/plate
5.0ul/plate

Key: Condition of background lawn
Good
Fair
+
/

2

+S9
1 2

Poor
-

Table 10. Ames test background lawn condition
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TA100

-S9
1

2

+S9
1
2

toxic
t

APPENDIX B
Tables of results
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Dosage
(mg/plate)

Revertants per plate
TA98
-S9

.312
.625
1.25
2.5
5.0
10.0

33.6
24.3
15.6
21.3
15.5
77.3

TA100
-S9

+S9

+S9

38.5
27.5
24.16
35.0
69.0
85.6

163.3
178.0
220.6
200.8
117.3
76.0

74.5
144.0
76.6
51.6
97.5
76.0

Negative control 13.1

19.6

57.9

81.4

Positive Control 653.1

908.1

861.3

1321.5

Table 11. Mutagenicity of DMSO eluates of freshly mixed AHPlus

Dosage
(mg/plate)

Revertants per plate
TA98
-S9

.312
.625
1.25
2.5
5.0
10.0

27.0
22.5
17.8
23.8
15.8
38.3

Negative control 13.1
Positive Control 653.1

TA100
-S9

+S9
37.3
31.0
27.3
35.0
15.83
38.3
19.6
908.1

+S9

59.5
62.5
74.5
138.0
139.3
145.5

58.6
75.0
74.5
71.5
139.3
145.5

57.9

81.4

861.3

1321.5

Table 12. Mutagenicity of DMSO eluates of AHPlus after setting 24h.
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Dosage
(mg/plate)

Revertants per plate
TA98
-S9

.312
.625
1.25
2.5
5.0
10.0

17.0
11.8
16.5
21.3
19.6
19.3

Negative control 13.1
Positive Control 653.1

+S9
19.3
21.3
25.1
20.8
22.1
27.0
19.6

TA100
-S9

+S9

79.6
73.1
67.1
64.1
54.8
65.5

91.6
78.5
86.8
62.6
74.1
70.5

57.9

908.1

861.3

81.4
1321.5

Table 13. Mutagenicity of DMSO eluates of freshly mixed RSA Roekoseal
Automix.

Dosage
(mg/plate)

Revertants per plate
TA98
-S9

+S9

TA100
-S9

16.3
24.0
17.5
13.5
20.5
21.3

25.3
23.3
23.1
21.8
21.5
16.5

62.3
72.5
68.0
60.3
51.8
62.3

65.5
66.3
67.6
69.0
62.6
57.3

Negative control 13.1

19.6

57.9

81.4

Positive Control 653.1

908.1

861.3

1321.5

.312
.625
1.25
2.5
5.0
10.0

+S9

Table 14. Mutagenicity of DMSO eluates of RSA Roekoseal Automix after
setting 24h.
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Comparisons with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-110.742
-54.909
-112.909
-87.909
-101.409
-112.242
-117.575

Positive values show pairs of means that are significantly different.
Table 15. Statistical analysis of AHPlus after mixing in TA100 with S9

Comparisons with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-7.273
7.393
50.060
30.227
-53.273
-94.607
-112.773

Positive values show pairs of means that are significantly different.
Table 16. Statistical analysis of AHPlus after mixing in TA100 without S9
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Comparisons with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-17.096
-33.4293
-32.9293
-29.9293
18.2373
24.4040
-39.7627

Positive values show pairs of means that are significantly different.
Table17. Statistical analysis of AHPlus after setting 24h in TA100 with S9.

Comparisons with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-32.1554
-29.1554
-17.1554
46.3446
47.6779
53.8446
-33.8221

Positive values show pairs of means that are significantly different.
Table18. Statistical analysis of AHPlus after setting 24h in TA100 without S9.
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Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

11.3132
1.9799
-6.6868
-1.0201
-6.8534
54.9799
-9.1868

Positive values show pairs of means that are significantly different.
Table19. Statistical analysis of AHPlus after mixing in TA98 without S9.

Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/. 1ul
control

-108.294
-119.294
-122.628
-111.794
-77.794
61.128
-127.128

Positive values show pairs of means that are significantly different.
Table 20. Statistical analysis of AHPlus after mixing in TA98 with S9.
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Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

2.0316
-2.4684
-7.1351
-1.1351
-9.1351
13.3649
-11.8017

Positive values show pairs of means that are significantly different.
Table 21. Statistical analysis of AHPlus after setting 24h in TA98 without S9

Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-0.5745
-6.9079
-10.5745
-2.9079
-14.4079
0.4255
-18.2412

Positive values show pairs of means that are significantly different.
Table 22. Statistical analysis of AHPlus after setting 24h in TA 98 with S9.
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Comparisons with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-9.9580
-12.4580
-10.4580
-5.6247
-7.2913
-7.6247
-13.7913

Positive values show pairs of means that are significantly different.
Table 23. Statistical analysis of RSA Roekoseal Automix after mixing in TA98 without
S9.

Comparisons with a control using Dunnett's Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-12.0441
-10.7107
-6.8774
-11.2107
-9.8774
-5.0441
-12.3774

Positive values show pairs of means that are significantly different.
Table 24. Statistical analysis of RSA Roekoseal Automix after mixing in TA98 with S9.
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Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-14.9569
-16.9569
-17.1235
-18.4569
-18.7902
-17.4569
-20.6235

Positive values show pairs of means that are significantly different.
Table 25. Statistical analysis of RSA Roekoseal Automix after setting 24 h in TA98 with
S9.

Comparison with control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-12.0953
-4.4286
-10.9286
-14.9286
-7.9286
-7.0953
-15.2620

Positive values show pairs of means that are significantly different.
Table 26. Statistical analysis of RSA Roekoseal Automix after setting 24 h in TA98
without S9.
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Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-23.7418
-31.2418
-28.5751
-15.4084
-26.9084
-23.2418
-34.0751

Positive values show pairs of means that are significantly different.
Table 27. Statistical analysis of RSA Roekoseal Automix after mixing in TA100 with
S9.

Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-2.4291
-4.0709
-10.0709
-13.0709
-16.4042
-11.7376
-19.4042

Positive values show pairs of means that are significantly different.
Table 28. Statistical analysis of RSA Roekoseal Automix after mixing in TA100 without
S9.
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Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-19.9727
-20.8060
-22.1393
-23.4727
-17.1393
-11.8060
-35.8060

Positive values show pairs of means that are significantly different.
Table 29. Statistical analysis of RSA Roekoseal Automix after setting 24h in TA100 with
S9.

Comparison with a control using Dunnett’s Method
Alpha= 0.05

Abs(Dif) – LSD

Control

.312mg/.1ul
.625mg/.1ul
1.25mg/.1ul
2.5mg/.1ul
5mg/.1ul
10mg/.1ul
control

-21.0723
-10.9056
-15.4056
-23.0723
-19.5723
-21.0723
-25.5723

Positive values show pairs of means that are significantly different.
Table 30. Statistical analysis of RSA Roekoseal Automix after setting 24h in TA100
without S9.
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ANALYSIS OF VARIANCE FOR TA98 AND TA100
Level

Least square mean

Std error

Mean

TA100

89.4791

1.88

89.4792

TA98

26.7534

1.88

26.7535

Table 31. Analysis of variance for TA98 and TA100.
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APPENDIX C
Diagrams
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Diagram 1. Mutagenicity of freshly mixed RSA Roekoseal and AHPlus in TA98
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Diagram 2. Mutagenicity of freshly mixed RSA Roekoseal and AHPlus in TA100.
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Diagram 3. Mutagenicity of 24h set RSA Roekoseal and AHPlus in TA98.
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Diagram 4. Mutagenicity of 24 h set RSA Roekoseal and AHPlus in TA100.
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